Tom Gardner is founder and managing member of Omeza, LLC (patent-pending omega oil for compromised skin), co-founder of Key View Labs (cognitive health dietary supplements), former chairman of IntegriChain (marketing analytics platform or the pharmaceutical industry; old to Accel-KKR), and former chairman of MMIT (managed market insights and technology for the pharmaceuticals industry; sold to Welsh Carson). He is an investor in and board chairman of Florida Mobile Physicians (home care medicine) and co-founder of BRIDGE Angel Investors.
Prior to Key View, Tom was CEO of several public and private companies including Nucryst Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to Procter & Gamble), Data monitor (IPO on London Stock Exchange), Base Ten Systems (assets sold to Smiths Aerospace and ABB Group), and Access Health (sold to HBOC, now part of McKesson). Earlier, Tom held marketing and general management positions at Procter &Gamble and Johnson & Johnson. He earned a B.A. in Economics and Mathematics from the University of St. Thomas (Minnesota) and has been a guest lecturer on marketing channels at Northwestern University’s Kellogg Graduate School of Management.